Skip to main content
. 2014 Jun 17;38(3):230–239. doi: 10.4093/dmj.2014.38.3.230

Table 3.

Prescription status of therapy for diabetes in patient using oral hypoglycemic agent only

graphic file with name dmj-38-230-i003.jpg

OHA, oral hypoglycemic agent; Met, metformin; SU, sulfonylurea; AGI, α-glucosidase inhibitor; GLP-1, glucagon-like peptide-1; Glinide, meglitinide; TZD, thiazolidinedione; DPP4I, dipeptidyl peptidase 4 inhibitor.